Recap: Alpha Tau Medical Q1 Earnings
Portfolio Pulse from Benzinga Insights
Alpha Tau Medical (NASDAQ:DRTS) reported Q1 earnings with an EPS of $-0.12, missing estimates by 9.09%. Revenues were down $0 from the same period last year. Last quarter, the company beat EPS estimates, followed by a 1.52% drop in share price.
May 23, 2023 | 9:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Alpha Tau Medical's Q1 earnings missed estimates with an EPS of $-0.12, a 9.09% miss. Revenues were down $0 from last year. Last quarter, beating EPS estimates led to a 1.52% drop in share price.
Alpha Tau Medical's Q1 earnings missed estimates by 9.09%, which could negatively impact the stock price in the short term. Additionally, revenues were down from the same period last year. Last quarter, the company experienced a 1.52% drop in share price after beating EPS estimates, suggesting that the market may react negatively to this earnings miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100